Article Details
Retrieved on: 2021-02-16 21:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Since 1990, several anti-IgE monoclonal antibodies (mAbs) have been developed (Figure 2). The results of two Phase 3 clinical trials of ligelizumab are ...
Article found on: www.dovepress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here